Your browser doesn't support javascript.
loading
Non-Pharmacological Therapeutic Options for Liver Metastases in Advanced Neuroendocrine Tumors.
Dermine, Solène; Palmieri, Lola-Jade; Lavolé, Julie; Barré, Amélie; Dohan, Antony; Abou Ali, Einas; Cottereau, Anne-Ségolène; Gaujoux, Sébastien; Brezault, Catherine; Chaussade, Stanislas; Coriat, Romain.
Afiliação
  • Dermine S; Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Palmieri LJ; Department of Gastroenterology, Cochin Teaching Hospital, Université de Paris, 75014 Paris, France.
  • Lavolé J; Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Barré A; Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Dohan A; Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Abou Ali E; Department of Gastroenterology, Cochin Teaching Hospital, Université de Paris, 75014 Paris, France.
  • Cottereau AS; Department of Gastroenterology, Cochin Teaching Hospital, Université de Paris, 75014 Paris, France.
  • Gaujoux S; Department of Radiology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Brezault C; Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, 75014 Paris, France.
  • Chaussade S; Department of Gastroenterology, Cochin Teaching Hospital, Université de Paris, 75014 Paris, France.
  • Coriat R; Department of Gastroenterology, Cochin Teaching Hospital, Université de Paris, 75014 Paris, France.
J Clin Med ; 8(11)2019 Nov 07.
Article em En | MEDLINE | ID: mdl-31703375
ABSTRACT
The incidence of liver metastasis in digestive neuroendocrine tumors is high. Their presence appears as an important prognostic factor in terms of quality of life and survival. These tumors may be symptomatic because of the tumor burden itself and/or the hormonal hyper-secretion induced by the tumor. Surgery is the treatment of choice for resectable tumors and metastasis. Nevertheless, surgery is only possible in a small number of cases. The management of non-resectable liver metastasis is a challenge. The literature is rich but consists predominantly in small retrospective series with a low level of proof. Thus, the choice of one technique over another could be difficult. Local ablative techniques (radiofrequency) or trans-catheter intra-arterial liver-directed treatments (hepatic artery embolization, chemo-embolization, and radio-embolization) are frequently considered for liver metastasis. In the present review, we focus on these different therapeutic approaches in advanced neuroendocrine tumors, results (clinical and radiological), and overall efficacy, and summarize recommendations to help physicians in their clinical practice.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França